Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion
Go back to Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion| Danaher Corp. (NYSE: DHR) | Delayed: 227.33 +2.84 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $224.49 | 52 Week High | $102.79 | |||
| Open | $223.40 | 52 Week Low | $75.71 | |||
| Day High | $228.38 | P/E | 59.82 | |||
| Day Low | $222.10 | EPS | $3.80 | |||
| Volume | 4,898,611 | |||||
| General Electric (NYSE: GE) | Delayed: 318.24 -8.85 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $327.09 | 52 Week High | $33.00 | |||
| Open | $321.46 | 52 Week Low | $27.10 | |||
| Day High | $323.00 | P/E | 216.49 | |||
| Day Low | $315.24 | EPS | $1.47 | |||
| Volume | 4,172,997 | |||||
